Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details)

v3.23.3
Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details) - shares
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 18,306,366 16,422,513
Stock options    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 1,746,177 1,547,190
Unvested Restricted Stock Units    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 2,417,891 521,316
Warrants    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 14,142,298 14,354,007